SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
Former Amadeus President and Southwest Airlines SVP & CIO Join Payment Orchestration Leader to Drive Next Phase of Travel Retailing Innovation DALLAS, Sept....
Setting a New Standard for Innovation and Circularity in the Global Textile Industry DONGGUAN, China, Sept. 16, 2025 /PRNewswire/ -- China's first fully automated...
MELBOURNE, Australia, Sept. 16, 2025 /PRNewswire/ -- The Australian Sports Technologies Network (ASTN) and Dailymotion Pro, a global video solution provider, are pleased to announce...
Potential to reduce the risk of erectile dysfunction and urinary incontinence PERTH, Australia, Sept. 16, 2025 /PRNewswire/ -- Regenerative medicine company Orthocell Limited (ASX:OCC,...
We are advised by Desilo that journalists and other readers should disregard the news release, DESILO and Cornami Launch Encrypted AI Model That Balances...
